Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy
The MINDBP study will enroll 90 pregnant women at risk for HDP across two sites (MCW and Brown) and randomize them to: (1) mindfulness training (MT) plus wearable biosensors, (2) MT alone, or (3) routine prenatal care. MT participants will receive 8 weekly phone-based MT sessions plus two booster sessions at 1 and 2 months post-intervention. The primary outcome is study feasibility.
Conditions studied
Preeclampsia
About this study
The MINDBP study will enroll 90 pregnant women at risk for HDP across two sites (MCW and Brown) and randomize them to: (1) mindfulness training (MT) plus wearable biosensors, (2) MT alone, or (3) routine prenatal care. MT participants will receive 8 weekly phone-based MT sessions plus two booster sessions at 1 and 2 months post-intervention. The primary outcome is study feasibility.
Interventions
- Behavioral: Mindfulness training — Mindfulness training with trained instructors
- Behavioral: Garmin Vivoactive 4 watch — Biofeedback with a wearable biosensor that continuously monitors heart rate variability and generates stress scores.
Primary outcomes
- Feasibility of multisite RCT (3 years)
Eligibility information
Study locations
- Brown University, Providence, Rhode Island 02904 United States
- Medical College of Wisconsin, Milwaukee, Wisconsin 53226 United States
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.